Logo image of CTEK

CYNERGISTEK INC/DE (CTEK) Stock Price, Forecast & Analysis

USA - NYSE Arca - NYSEARCA:CTEK - US23258P1057 - Common Stock

1.25 USD
+0.02 (+1.63%)
Last: 8/31/2022, 8:04:02 PM
1.25 USD
0 (0%)
After Hours: 8/31/2022, 8:04:02 PM

CTEK Key Statistics, Chart & Performance

Key Statistics
Market Cap16.57M
Revenue(TTM)16.86M
Net Income(TTM)-10.43M
Shares13.26M
Float12.01M
52 Week High2.04
52 Week Low0.58
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.29
PEN/A
Fwd PEN/A
Earnings (Next)11-09
IPO2017-02-14
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
CTEK short term performance overview.The bars show the price performance of CTEK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10

CTEK long term performance overview.The bars show the price performance of CTEK in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of CTEK is 1.25 USD. In the past month the price increased by 4.17%. In the past year, price decreased by -36.55%.

CYNERGISTEK INC/DE / CTEK Daily stock chart

CTEK Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to CTEK. When comparing the yearly performance of all stocks, CTEK is a bad performer in the overall market: 69.77% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

CTEK Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CTEK. The financial health of CTEK is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CTEK Financial Highlights

Over the last trailing twelve months CTEK reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS decreased by -52.63% compared to the year before.


Industry RankSector Rank
PM (TTM) -61.88%
ROA -55.8%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-16037.89%
Sales Q2Q%1.76%
EPS 1Y (TTM)-52.63%
Revenue 1Y (TTM)-2.26%

CTEK Forecast & Estimates

6 analysts have analysed CTEK and the average price target is 1.27 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 1.25.

For the next year, analysts expect an EPS growth of -23.1% and a revenue growth 16.51% for CTEK


Analysts
Analysts43.33
Price Target1.27 (1.6%)
EPS Next Y-23.1%
Revenue Next Year16.51%

CTEK Ownership

Ownership
Inst Owners5.97%
Ins Owners2.94%
Short Float %N/A
Short RatioN/A

CTEK Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.88 103.28B
CI THE CIGNA GROUP 9.78 74.25B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 128.01 23.55B
LH LABCORP HOLDINGS INC 17 22.29B
DGX QUEST DIAGNOSTICS INC 19.49 21.16B
GH GUARDANT HEALTH INC N/A 14.43B
DVA DAVITA INC 11.47 7.47B
BTSG BRIGHTSPRING HEALTH SERVICES 38.82 7.14B
HIMS HIMS & HERS HEALTH INC 57.83 7.11B
CHE CHEMED CORP 20.86 6.50B
OPCH OPTION CARE HEALTH INC 24.23 5.73B
RDNT RADNET INC 192.08 5.63B

Related stock screener links

About CTEK

Company Profile

CTEK logo image CynergisTek, Inc. engages in the provision of cybersecurity, privacy, and compliance services for companies. The company is headquartered in Austin, Texas and currently employs 89 full-time employees. The company went IPO on 2017-02-14. The firm is engaged in the business of providing companies with cybersecurity, privacy and compliance services through its assessment and technical testing, remediation, management, and validation services. The company serves companies in regulated industries, including healthcare, higher education, technology, government, manufacturing, and the financial sector through the CynergisTek, Backbone Consulting and Redspin brands. Its services are categorized into four service groups, which include Assess, Build, Manage, and Validate. The Assess service identifies, measures, and test security and privacy risk of an organization’s readiness and verify and validate programs through information technology audits, technical testing, and risk and program assessments. The Build service develops policies and procedures and playbooks to help build out a range of risk management programs.

Company Info

CYNERGISTEK INC/DE

11940 Jollyville Road, Suite 300-N

Austin TEXAS 78759 US

CEO: Caleb Barlow

Employees: 89

CTEK Company Website

Phone: 19496140700.0

CYNERGISTEK INC/DE / CTEK FAQ

What does CYNERGISTEK INC/DE do?

CynergisTek, Inc. engages in the provision of cybersecurity, privacy, and compliance services for companies. The company is headquartered in Austin, Texas and currently employs 89 full-time employees. The company went IPO on 2017-02-14. The firm is engaged in the business of providing companies with cybersecurity, privacy and compliance services through its assessment and technical testing, remediation, management, and validation services. The company serves companies in regulated industries, including healthcare, higher education, technology, government, manufacturing, and the financial sector through the CynergisTek, Backbone Consulting and Redspin brands. Its services are categorized into four service groups, which include Assess, Build, Manage, and Validate. The Assess service identifies, measures, and test security and privacy risk of an organization’s readiness and verify and validate programs through information technology audits, technical testing, and risk and program assessments. The Build service develops policies and procedures and playbooks to help build out a range of risk management programs.


Can you provide the latest stock price for CYNERGISTEK INC/DE?

The current stock price of CTEK is 1.25 USD. The price increased by 1.63% in the last trading session.


Does CTEK stock pay dividends?

CTEK does not pay a dividend.


What is the ChartMill rating of CYNERGISTEK INC/DE stock?

CTEK has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Is CYNERGISTEK INC/DE (CTEK) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CTEK.


Is CYNERGISTEK INC/DE (CTEK) expected to grow?

The Revenue of CYNERGISTEK INC/DE (CTEK) is expected to grow by 16.51% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.